- Home
- PRTC vs QD Comparison
PRTC vs QD Comparison
Compare PRTC & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- QD
- Stock Information
- Founded
- PRTC 2015
- QD 2014
- Country
- PRTC United States
- QD China
- Employees
- PRTC N/A
- QD N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- QD Finance: Consumer Services
- Sector
- PRTC Health Care
- QD Finance
- Exchange
- PRTC Nasdaq
- QD Nasdaq
- Market Cap
- PRTC 439.8M
- QD 433.7M
- IPO Year
- PRTC N/A
- QD 2017
- Fundamental
- Price
- PRTC N/A
- QD $3.19
- Analyst Decision
- PRTC Buy
- QD
- Analyst Count
- PRTC 1
- QD 0
- Target Price
- PRTC $45.00
- QD N/A
- AVG Volume (30 Days)
- PRTC 5.9K
- QD 531.4K
- Earning Date
- PRTC 08-27-2025
- QD 05-30-2025
- Dividend Yield
- PRTC N/A
- QD N/A
- EPS Growth
- PRTC N/A
- QD N/A
- EPS
- PRTC 0.21
- QD 0.24
- Revenue
- PRTC $4,828,000.00
- QD $25,682,957.00
- Revenue This Year
- PRTC $35.98
- QD N/A
- Revenue Next Year
- PRTC $115.38
- QD N/A
- P/E Ratio
- PRTC $7.93
- QD $12.37
- Revenue Growth
- PRTC 44.98
- QD 16.24
- 52 Week Low
- PRTC $13.30
- QD $1.64
- 52 Week High
- PRTC $25.00
- QD $3.34
- Technical
- Relative Strength Index (RSI)
- PRTC 43.39
- QD 56.17
- Support Level
- PRTC $16.50
- QD $2.84
- Resistance Level
- PRTC $18.40
- QD $3.23
- Average True Range (ATR)
- PRTC 0.45
- QD 0.10
- MACD
- PRTC -0.17
- QD 0.01
- Stochastic Oscillator
- PRTC 20.88
- QD 44.27
About PRTC PureTech Health plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.